Acurx Site #103: Dr John Pullman — Butte, Montana

Acurx Site #103: Dr John Pullman is a clinical research site located in Butte, Montana, United States 59701.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Acurx Site #103: Dr John Pullman has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Acurx Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Butte

Browse all research sites in Montana · View every site in Butte

• Saint James Community Hospital and Cancer Treatment Center
• St. James Community Hospital
• SCL St. James Healthcare Hospital
• St. James Hospital
• St. James Healthcare Cancer Care
• Mercury Street Medical Group PLLC
• Research Site
• Mercury Street Medical
• Mercury Street Medical Group
• GSK Investigational Site
• Novo Nordisk Investigational Site
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acurx Site #103: Dr John Pullman?

Acurx Site #103: Dr John Pullman has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acurx Site #103: Dr John Pullman conducted?

Acurx Site #103: Dr John Pullman has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Acurx Site #103: Dr John Pullman accredited by Crixeo Clinical Trials?

Acurx Site #103: Dr John Pullman has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acurx Site #103: Dr John Pullman?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.